Swancor Advanced Materials (688585)
Search documents
上纬新材(688585) - 2025 Q2 - 季度业绩预告
2025-08-04 11:00
上纬新材料科技股份有限公司 关于 2025 年半年度业绩预告的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 (一)业绩预告期间 2025 年 1 月 1 日至 2025 年 6 月 30 日。 (二)业绩预告情况 证券代码:688585 证券简称:上纬新材 公告编号:064 1 1. 预计营业收入为 78,377.39 万元,较上年同期增加 12.50%; 2. 预计实现归属于上市公司股东的净利润 2,990.04 万元,较上年同期减 少 32.91%,归属于上市公司股东的扣除非经常性损益的净利润 2,604.14 万元,较上年同期减少 37.02%。 三、本期业绩变化的主要原因 公司归属于上市公司股东的净利润及归属于上市公司股东的扣除非经常性 损益的净利润较上年同期减少,主系海外销售运费及佣金增加约 1,100 万,二季 度新台币兑美金汇率急升 11.76%,致使海外美金应收账款造成的汇兑损失约 768 万,及研发可回收产品检测试验费增加约 572 万,使净利润较同期减少。 四、风 ...
上纬新材:预计上半年净利2990万元 同比减少32.91%
Ge Long Hui A P P· 2025-08-04 10:59
Core Viewpoint - The company expects a revenue increase for the first half of 2025 but anticipates a decline in net profit compared to the same period last year [1] Financial Performance - Projected revenue for the first half of 2025 is 784 million yuan, representing a 12.50% increase year-on-year [1] - Net profit attributable to shareholders is expected to be 29.90 million yuan, a decrease of 32.91% compared to the same period last year [1] Factors Affecting Performance - The decline in net profit is primarily due to increased overseas sales shipping costs and commissions, which rose by approximately 11 million yuan [1] - A significant appreciation of the New Taiwan Dollar against the US Dollar in the second quarter resulted in foreign exchange losses of about 7.68 million yuan [1] - Increased testing expenses for research and development of recyclable products contributed an additional cost of approximately 5.72 million yuan [1]
上纬新材:预计上半年度净利润2990万元,同比减少32.91%
Sou Hu Cai Jing· 2025-08-04 10:59
上纬新材8月4日公告,公司预计2025年半年度营业收入为7.84亿元,较上年同期增加12.50%,归属于上 市公司股东的净利润为2,990.04万元,较上年同期减少32.91%。业绩下滑主要由于海外销售运费及佣金 增加约1,100万元,二季度新台币兑美元汇率急升导致汇兑损失约768万元,以及研发可回收产品检测试 验费用增加约572万元。 ...
上纬新材:上半年净利润同比预减32.91%
Zheng Quan Shi Bao Wang· 2025-08-04 10:49
人民财讯8月4日电,上纬新材(688585)8月4日晚间发布2025年半年度业绩预告,预计上半年实现归属于 上市公司股东的净利润2990.04万元,较上年同期减少32.91%。主系海外销售运费及佣金增加约1100万 元,二季度新台币兑美金汇率急升11.76%,致使海外美金应收账款造成的汇兑损失约768万元,及研发 可回收产品检测试验费增加约572万元。 ...
上纬新材:核查工作完成 8月5日起复牌
Zheng Quan Shi Bao Wang· 2025-08-04 10:43
人民财讯8月4日电,上纬新材(688585)8月4日晚间公告,近期,公司就股票交易异常波动及严重异常波 动的相关事项进行了核查。鉴于相关核查工作已完成,经公司向上交所申请,公司股票将于8月5日开市 起复牌。目前公司基本面未发生重大变化。 ...
上纬新材:公司生产经营未发生重大变化,股票复牌
Xin Lang Cai Jing· 2025-08-04 10:41
Group 1 - The company's main business remains focused on the research, production, and sales of environmentally friendly high-performance corrosion-resistant materials, materials for wind turbine blades, new composite materials, and circular economy materials, with no significant changes reported [1] - The company's production and operations have not experienced any major changes, and the market environment or industry policies have not undergone significant adjustments [1] - The company's stock is set to resume trading on August 5, 2025 [1]
上纬新材:预计2025年半年度净利润同比下降32.91%
Xin Lang Cai Jing· 2025-08-04 10:41
上纬新材公告,预计2025年半年度营业收入为7.84亿元,较上年同期增加12.50%;归属于上市公司股东 的净利润预计为2990.04万元,较上年同期减少32.91%;归属于上市公司股东的扣除非经常性损益的净 利润预计为2604.14万元,较上年同期减少37.02%。本期业绩变化主要由于海外销售运费及佣金增加约 1100万,二季度新台币兑美金汇率急升11.76%,致使海外美金应收账款造成的汇兑损失约768万,及研 发可回收产品检测试验费增加约572万。 ...
新股发行及今日交易提示-20250804





HWABAO SECURITIES· 2025-08-04 08:25
Group 1: New Stock Offerings - Shenke Co., Ltd. (002633) has a tender offer period from July 29, 2025, to August 27, 2025[1] - ST Kelly (300326) has a tender offer period from July 17, 2025, to August 15, 2025[1] - ST Zitian (300280) has a tender offer period ending on July 21, 2025[1] Group 2: Market Alerts - Xizang Tourism (600749) reported severe abnormal fluctuations on July 31, 2025[1] - Tianlu Convertible Bonds (110060) announced significant market activity on July 30, 2025[1] - ST Suwu (600200) experienced unusual trading patterns on July 30, 2025[1] Group 3: Additional Announcements - Happiness Blue Ocean (300528) issued a notice on July 30, 2025, regarding market conditions[1] - Common Pharmaceutical (300966) provided updates on August 1, 2025, related to stock performance[1] - Dongjie Intelligent (300486) released a statement on August 1, 2025, concerning market volatility[1]
严重异常波动股票(25.8.4)
Xuan Gu Bao· 2025-08-04 00:19
Group 1 - The article discusses the monitoring of stock trading activities that exhibit significant abnormal fluctuations, particularly focusing on large buy or sell orders within a one-minute timeframe during continuous bidding phases [1] - The exchange will closely monitor trading behaviors related to stocks that show severe abnormal volatility within ten trading days following the occurrence [1] Group 2 - A list of stocks under abnormal fluctuation monitoring is provided, including their monitoring start and end dates, as well as the dates when the fluctuations began [2] - Specific stocks mentioned include "南方路机," "西藏旅游," "幸福蓝海," and "*ST苏吴," among others, with varying monitoring periods [2]
7月十大牛股出炉:上纬新材逾1083%涨幅问鼎榜首
Di Yi Cai Jing Zi Xun· 2025-08-03 03:16
Market Overview - In July, the A-share market experienced an overall upward trend, with the Shanghai Composite Index rising by 3.74%, the Shenzhen Component Index increasing by 5.20%, and the ChiNext Index gaining 8.14% by the end of July [1] Top Performing Stocks - The top-performing stock in July was Shangwei New Materials, which saw a staggering increase of 1083.42%, making it the first stock to achieve a tenfold increase in A-shares since 2025 [3][6] - Guangshengtang ranked second with a monthly increase of 218.94%, driven by significant progress in its hepatitis B innovative drug development [3][7] - Hengli Drilling Tools achieved a monthly increase of 191.24%, boosted by the commencement of a major hydropower project in the Yarlung Tsangpo River basin [3][9] Detailed Stock Performance - **Shangwei New Materials**: - The stock price surged from 9.34 yuan to 92.07 yuan between July 9 and July 30, with 11 trading days experiencing a 20% limit up [6] - The surge was attributed to an announcement regarding a significant acquisition that would change the controlling shareholder [6] - The company reported a net profit of 88.68 million yuan for 2024, a year-on-year increase of 25.01% [6] - **Guangshengtang**: - The stock had two trading days with a 20% limit up, with a total increase of 218.94% for the month [7] - The company received ethical review approval for its phase III clinical trial of GST-HG141 and had another drug, GST-HG131, recognized as a breakthrough therapy [7][8] - Guangshengtang has been a key player in the antiviral and liver disease sectors for over 20 years [8] - **Hengli Drilling Tools**: - The stock experienced three trading days with a 30% limit up, culminating in a 191.24% increase for the month [9] - The rise was linked to the launch of a significant hydropower project with an investment of approximately 1.2 trillion yuan [9] - Hengli specializes in the research, manufacturing, and sales of various drilling tools for construction projects [9]